These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 192450)

  • 1. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):463-71. PubMed ID: 202652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic requirements for hormone-induced resistance to antibody-complement mediated killing of tumor cells.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1977 Sep; 119(3):789-94. PubMed ID: 894026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3204-8. PubMed ID: 52405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):472-80. PubMed ID: 202653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complement.
    Lo TN; Boyle MD
    Cancer Res; 1979 Aug; 39(8):3156-62. PubMed ID: 222445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1979 Dec; 63(6):1475-83. PubMed ID: 292816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in susceptibility to cytotoxic antibody among tumor cells surviving exposure to chemotherapeutic agents.
    Shapiro SJ; Leibson PJ; Loken MR; Schreiber H
    Cancer Res; 1982 Jul; 42(7):2622-7. PubMed ID: 7083155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.
    Momparler RL; Karon M; Siegel SE; Avila F
    Cancer Res; 1976 Aug; 36(8):2891-5. PubMed ID: 1277199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes.
    Stevens J; Stevens YW
    Cancer Res; 1975 Aug; 35(8):2145-53. PubMed ID: 1149029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
    Glazer RI; Hartman KD; Knode MC
    Mol Pharmacol; 1983 Sep; 24(2):309-15. PubMed ID: 6888372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack.
    Schlager SI; Ohanian SH
    Science; 1977 Aug; 197(4305):773-6. PubMed ID: 196331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.